ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,344Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 298

$747K Total Retail Price of All Prescriptions

Rank: 2 out of 298

627 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 15,484 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 792 669 1 1
AMLODIPINE BESYLATE 695 646 2 6
OMEPRAZOLE 678 598 3 3
METOPROLOL TARTRATE 654 639 4 9
FUROSEMIDE 534 505 5 5
WARFARIN SODIUM 483 468 6 7
POTASSIUM CHLORIDE 432 395 7 11
CITALOPRAM HBR 391 361 8 17
METOPROLOL SUCCINATE 377 348 9 12
LISINOPRIL 371 330 10 4
HYDROCHLOROTHIAZIDE 366 348 11 13
SIMVASTATIN 350 301 12 2
HYDROCODONE-ACETAMINOPHEN 346 329 S3 13 8
LOSARTAN POTASSIUM 286 267 14 18
METFORMIN HCL 269 228 15 10
PREDNISONE 261 249 16 33
ATORVASTATIN CALCIUM 212 193 17 14
POLYETHYLENE GLYCOL 3350 201 172 18 29
TRIAMTERENE-HCTZ 194 175 19 43
GLYBURIDE 190 170 R 20 76
RANITIDINE HCL 190 175 20 59
RISPERIDONE 186 186 22 54
SERTRALINE HCL 184 182 23 19
ATENOLOL 170 170 24 16
MIRTAZAPINE 165 163 25 37
CRESTOR 154 139 26 26
CLOPIDOGREL 147 147 27 36
PRAVASTATIN SODIUM 135 113 28 31
ISOSORBIDE MONONITRATE ER 134 134 29 45
TAMSULOSIN HCL 133 130 30 24
ALLOPURINOL 133 126 30 28
CLONIDINE HCL 128 128 32 82
DIGOXIN 121 119 33 27
DONEPEZIL HCL 120 120 34 22
NAMENDA 119 119 35 35
SPIRONOLACTONE 113 112 36 34
KLOR-CON 10 112 97 37 61
TRAMADOL HCL 112 93 37 15
GABAPENTIN 111 93 39 20
CARVEDILOL 109 106 40 23
CIPROFLOXACIN HCL 105 93 41 56
PLAVIX 104 104 42 70
LEVOFLOXACIN 104 95 42 101
FLUTICASONE PROPIONATE 100 76 44 38
ADVAIR DISKUS 93 78 45 46
AVODART 93 93 45 115
PROAIR HFA 89 83 47 96
HUMULIN 70-30 88 80 48 160
NEXIUM 85 58 49 40
TRIAMCINOLONE ACETONIDE 85 68 49 123
MELOXICAM 83 72 51 41
MECLIZINE HCL 79 79 52 203
SPIRIVA 79 59 52 55
FENTANYL 73 73 S2 54 32
ESCITALOPRAM OXALATE 73 73 54 89
NOVOLIN 70-30 72 72 56 184
DILTIAZEM ER 71 57 57 116
TRIAMTERENE-HYDROCHLOROTHIAZID 71 71 57 150
ALBUTEROL SULFATE 70 70 59 75
BACLOFEN 70 50 59 97
TRAMADOL HCL-ACETAMINOPHEN 69 68 61 129
PHENYTOIN SODIUM EXTENDED 66 55 62 190
SUMATRIPTAN SUCCINATE 65 0 63 193
DICLOFENAC SODIUM 65 59 63 138
PEN NEEDLE 64 53 65 190
AMOX TR-POTASSIUM CLAVULANATE 63 59 66 154
NITROGLYCERIN PATCH 62 62 67 106
AMOXICILLIN 62 52 67 143
FENOFIBRATE 61 47 69 62
VENLAFAXINE HCL ER 60 32 70 90
PROPRANOLOL HCL 59 41 71 85
FINASTERIDE 58 58 72 66
DETROL LA 54 44 73 151
DILANTIN 54 50 73 229
CEFPROZIL 53 44 75 188
TRAZODONE HCL 53 40 75 39
DOXYCYCLINE HYCLATE 52 45 77 168
PAROXETINE HCL 52 43 77 48
DOXAZOSIN MESYLATE 51 51 79 77
GALANTAMINE HBR 50 50 80 194
NIASPAN 50 33 80 245
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.